LTCR‑H3‑3
Biomarker study for advanced primary HBV‑HCC
Phase 1Upcoming
Key Facts
About Lion TCR
Pioneering mRNA‑based TCR‑T cell immunotherapy for HBV‑driven liver cancer in Asia.
View full company profileBiomarker study for advanced primary HBV‑HCC
Pioneering mRNA‑based TCR‑T cell immunotherapy for HBV‑driven liver cancer in Asia.
View full company profile